Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
Shionogi acquires IntraBio to bolster rare disease business
Shionogi is scooping up IntraBio and its lead asset, Aqneursa, in a $2 billion deal just weeks after IntraBio's key FDA label expansion.
Donavyn Coffey
Oct 5, 2026 11:33am
Novo cites production site corrections amid hemophilia FDA delay
Oct 5, 2026 7:15am
For biopharma manufacturing at speed and scale, the future is flexible
Brought to you by
Resilience
FDA dings Evolus for blurred lines between Botox rival, lipstick
Oct 5, 2026 5:35am
Clinical trials reach a new automation inflection point
Brought to you by
IQVIA
Lilly’s BTK drug Jaypirca enters first-line CLL
Oct 2, 2026 4:15pm
